Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
for the ZOE-50/70 Study Group, on behalf of GSK
科研成果: 期刊稿件 › 文章 › 同行评审
31
引用
（Scopus）